Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice
- 31 May 1998
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 38 (2), 117-130
- https://doi.org/10.1016/s0166-3542(98)00019-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Interleukin-12: Potential Clinical Applications in the Treatment and Prevention of Infectious DiseasesDrugs, 1996
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- The role of interleukin 12 in the immune response, disease and therapyImmunology Today, 1994
- Influenza A virus replication is inhibited by tumor necrosis factor-α in vitroArchiv für die gesamte Virusforschung, 1994
- Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cellsEuropean Journal of Immunology, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus ChallengeThe Journal of Infectious Diseases, 1993
- Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.The Journal of Experimental Medicine, 1992
- Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virusJournal of General Virology, 1990
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989